Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Completed 2Withdrawn 1Recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 28Myeloid 9Dermatologic 8Plasma cell 3Genitourinary 3Thoracic 2Lymphoid 2Gynecologic 2Classical hematology 2CNS 2Tumor-Agnostic 1Other neoplasm 1

Conditions

Neuroblastoma 2Wilms Tumor 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Tretinoin × CNS × Clear all
NCT00017225 2013-08-02

Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 2 Completed
CNS

Neuroblastoma

NCT00001509 2008-03-04

A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
60 enrolled
CNSGenitourinary

Wilms Tumor, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡